肝硬化诊断和治疗中的关键问题

StephenW

Critical issues in the diagnosis and treatment of liver cirrhosis
Xing Wang Bin Wu
Gastroenterology Report, goz024, https://doi.org/10.1093/gastro/goz024
Published:
10 June 2019

Issue Section:
Editorial

Liver cirrhosis (LC) is a worldwide health problem that is associated with various complications and high mortality. Although, in the past four decades, the incidence of hepatitis B continuously decreased and a promising cure for hepatitis C was developed, LC remains a formidable challenge in clinical practice due to the ever-increasing incidences of alcoholic and non-alcoholic fatty liver diseases, autoimmune-related liver disease and drug-induced liver disease [1–3]. Our survey data showed a significant increase in the inpatient percentages of alcoholic LC and autoimmune LC, with concomitant decreases in viral hepatitis LC, which contributes to the overall increasing incidence of LC in China [4]. As a spacious country with a large population, a discrepancy exists in medical specialties and several topics should therefore receive more attention in the management of LC. To aid broad gastroenterologists and heatologists as well as physicians, we identified the following critical issues in the diagnosis and treatment of LC.
Etiological overlap must receive attention in

StephenW

肝硬化诊断和治疗中的关键问题
邢王斌吴
胃肠病学报告，goz024，https：//doi.org/10.1093/gastro/goz024
发布时间：
2019年6月10日

问题部分：
社论

肝硬化（LC）是一种全球性的健康问题，与各种并发症和高死亡率有关。尽管在过去的四十年中，乙型肝炎的发病率持续下降，并且开发了一种治疗丙型肝炎的有希望的治疗方法，但由于酒精和非酒精性脂肪性肝病的发病率不断增加，LC在临床实践中仍然是一项艰巨的挑战，自身免疫性肝病和药物性肝病[1-3]。我们的调查数据显示，酒精性LC和自身免疫性LC的住院百分比显着增加，同时病毒性肝炎LC降低，这有助于中国LC的总体发病率增加[4]。作为一个人口众多的宽敞国家，医学专业存在差异，因此在LC的管理中应该更多地关注几个主题。为了帮助广泛的胃肠病学家和热病学家以及医生，我们在LC的诊断和治疗中发现了以下关键问题。

StephenW

https://academic.oup.com/gastro/ ... stro/goz024/5513231